Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Total Debt (2023 - 2025)

Historic Total Debt for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to $99.9 million.

  • Inhibrx Biosciences' Total Debt changed N/A to $99.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.9 million, marking a year-over-year change of. This contributed to the annual value of $207.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Inhibrx Biosciences reported Total Debt of $99.9 million as of Q3 2025.
  • Inhibrx Biosciences' 5-year Total Debt high stood at $207.0 million for Q4 2023, and its period low was $98.7 million during Q1 2025.